CORCEPT THERAPEUTICS INC(NASDAQ:CORT) stock News

CORT Latest News, Press Relases and Analysis

All

Press Releases

6 days ago - By: Chartmill

CORCEPT THERAPEUTICS INC (NASDAQ:CORT) Embodies the "Affordable Growth" Investment Strategy

8 days ago - By: Chartmill

Corcept Therapeutics Inc (NASDAQ:CORT): A Strong Growth Stock with Solid Fundamentals and Technical Upside

24 days ago - By: Zacks Investment Research - Mentions: CRMD IMCR

CORT's Q2 Earnings Top Mark, Revenues Lag, '25 View Cut, Stock Down

24 days ago - By: Benzinga

If You Invested $100 In This Stock 5 Years Ago, You Would Have This Much Today

25 days ago - By: Zacks Investment Research - Mentions: SPRY

Corcept Therapeutics (CORT) Tops Q2 Earnings Estimates

25 days ago - By: Corcept Therapeutics Incorporated

Corcept Therapeutics Announces Second Quarter Financial Results and Provides Corporate Update

26 days ago - By: Benzinga - Mentions: BSAC BGC RMNI MTZ ...

Earnings Scheduled For July 31, 2025

a month ago - By: Yahoo Finance

Corcept Therapeutics Advances Pipeline Fueling Growth With Controlled Risk

a month ago - By: Yahoo Finance - Mentions: GS

Corcept (CORT) Advances Ovarian Cancer Therapy with FDA Filing for Relacorilant

a month ago - By: Corcept Therapeutics Incorporated

Corcept Therapeutics to Announce Second Quarter Financial Results, Provide Corporate Update and Host Conference Call

a month ago - By: Yahoo Finance

Corcept Advances Cancer Drug as Analysts Back Strong Growth Prospects

a month ago - By: Corcept Therapeutics Incorporated

Corcept Submits New Drug Application for Relacorilant as a Treatment for Patients with Platinum-Resistant Ovarian Cancer

2 months ago - By: Yahoo Finance

Corcept Therapeutics (CORT) Announces Pivotal Data from Phase 3 ROSELLA Trial

2 months ago - By: Yahoo Finance - Mentions: NRG CEG VST

Jim Cramer on NRG: “Wall Street Loves the Fact That They’re Doubling Down on Power Generation”

2 months ago - By: Corcept Therapeutics Incorporated

Corcept Presents Data from Treatment Phase of CATALYST Trial at American Diabetes Association’s 85th Scientific Sessions with Simultaneous Publication in Diabetes Care

3 months ago - By: Zacks Investment Research - Mentions: IVZ AWI ADMA

Should Invesco S&P SmallCap Quality ETF (XSHQ) Be on Your Investing Radar?

3 months ago - By: Corcept Therapeutics Incorporated

Corcept Presents Results from Phase 2 Study of Dazucorilant in Patients with Amyotrophic Lateral Sclerosis (ALS) at ENCALS 2025 Annual Meeting

3 months ago - By: Zacks Investment Research - Mentions: UTHR

Corcept (CORT) Down 1.7% Since Last Earnings Report: Can It Rebound?

3 months ago - By: Yahoo Finance - Mentions: TSLA DHI CMG

CORCEPT THERAPEUTICS INC (CORT) Stock News